“Conclusion: In patients on a maintenance dose of paricalcitol , dosing doxercalciferol at 55–60% of the paricalcitol dose results in comparable inhibition of PTH.”
“Linear regression analysis demonstrated a conversion factor of 0.57 for the dose of doxercalciferol relative to paricalcitol resulting in equivalent suppression of iPTH.”